Abstract | PURPOSE: METHODS: A 42-year-old man who developed pseudotumor cerebri 7 years after starting human recombinant GH treatment is presented. RESULTS: CONCLUSIONS:
|
Authors | A Vischi, S Guerriero, G Giancipoli, V Lorusso, G Sborgia |
Journal | European journal of ophthalmology
(Eur J Ophthalmol)
2006 Jan-Feb
Vol. 16
Issue 1
Pg. 178-80
ISSN: 1120-6721 [Print] United States |
PMID | 16496267
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Growth Hormone
(adverse effects)
- Humans
- Male
- Papilledema
(chemically induced, diagnosis)
- Pseudotumor Cerebri
(chemically induced, diagnosis)
- Syndrome
|